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The increasing levels of multi-drug resistance in human pathogenic 
bacteria are compromising our ability 
to treat infectious disease. Since antibi-
otic resistance determinants are readily 
exchanged between bacteria through 
lateral gene transfer, there is an increas-
ing interest in investigating reservoirs 
of antibiotic resistance accessible to 
pathogens. Due to the high likelihood 
of contact and genetic exchange with 
pathogens during disease progression, 
the human microflora warrants special 
attention as perhaps the most accessible 
reservoir of resistance genes. Indeed, 
numerous previous studies have demon-
strated substantial antibiotic resistance 
in cultured isolates from the human 
microflora. By applying metagenomic 
functional selections, we recently dem-
onstrated that the functional repertoire 
of resistance genes in the human micro-
biome is much more diverse than sug-
gested using previous culture-dependent 
methods. We showed that many resis-
tance genes from cultured proteobacteria 
from human fecal samples are identical 
to resistance genes harbored by human 
pathogens, providing strong support for 
recent genetic exchange of this resis-
tance machinery. In contrast, most of 
the resistance genes we identified with 
culture independent metagenomic sam-
pling from the same samples were novel 
when compared to all known genes in 
public databases. While this clearly dem-
onstrates that the antibiotic resistance 
reservoir of the large fraction of the 
human microbiome recalcitrant to cul-
turing is severely under sampled, it may 
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also suggest that barriers exist to lateral 
gene transfer between these bacteria and 
readily cultured human pathogens. If we 
hope to turn the tide against multidrug 
resistant infections, we must urgently 
commit to quantitatively characteriz-
ing the resistance reservoirs encoded by 
our diverse human microbiomes, with a 
particular focus on routes of exchange 
of these reservoirs with other microbial 
communities.
The seemingly unchecked spread of mul-
tiple-antibiotic resistance in clinically-
relevant pathogenic microbes has begun 
to significantly dull the hue of the Golden 
Era of antibiotics, ostensibly launched in 
the 1940s with the industrial production of 
penicillin. A diverse set of molecular mech-
anisms of microbial antibiotic resistance 
have been elucidated, along with strong 
evidence for transfer of these mechanisms 
between different pathogenic microbes.1 
Selection of antibiotic-resistant strains has 
been accelerated by the imprudent prescrip-
tion and overuse of these life-saving che-
motherapeutics, particularly exacerbated 
by the widespread use of sub-therapeutic 
amounts of antibiotics as growth-promot-
ers in farm animals.2 Of further concern, 
the genetic and biochemical mechanisms 
which govern the evolution and dissemina-
tion of drug resistance can be engineered 
into or be naturally acquired by many 
putative bioterror agents, effectively annul-
ling our primary chemotherapeutics against 
these biological threats. For instance, a 
conjugative plasmid mediating multidrug 
resistance in Vibrio cholera was recently 
isolated, with 99.99% sequence identity 
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giving opportunity for genetic exchange 
between these microbes. Hence a virulent 
pathogen might acquire antibiotic resis-
tance through lateral transfer of antibiotic 
resistance genes harbored by antibiotic 
resistant commensal organisms. If antibi-
otic resistance genes have been exchanged 
between members of the human microbi-
ome and human pathogens, the evolution-
ary timeline of this exchange can be assayed 
by comparing the sequence identity of the 
relevant genetic machinery between the 
two groups.18
A common method for identifying genes 
in microbiomic samples that are homolo-
gous to previously identified resistance 
genes is PCR amplification using prim-
ers based on the sequences of the known 
genes. This has been successfully applied 
to study antibiotic resistance genes from 
cultured isolates and metagenomic sam-
ples from animals,19 humans20 and soil.21 
However, this approach requires complete 
sequence identity between primer regions 
of the templates queried and the known 
sequences, and hence has limited utility 
in the discovery of new genes. Given the 
sequence diversity of known resistance 
genes, this approach also requires the 
design of large numbers of primer sets and 
concomitantly large numbers of ampli-
fication reactions. Genes identified with 
a PCR-based method that differ in their 
encoded protein sequences from the known 
resistance genes must then be experimen-
tally verified to explicitly confirm their 
function. A complementary technique 
for elucidating antibiotic resistance genes 
is metagenomic functional selections4,22 
in which DNA is extracted from a source 
of interest and cloned directly into a sus-
ceptible indicator strain. Indicator strains 
harboring DNA fragments encoding anti-
biotic resistance genes can be selected for 
by subjecting the library of clones to par-
ticular antibiotics. Following the selection 
of antibiotic resistant clones, the metage-
nomic DNA insert can be sequenced to 
identify the causative antibiotic resistance 
gene. Standard metagenomic functional 
selections allow the interrogation of more 
than 109 base pairs of genetic information 
in a single selection and are consequently 
ideally suited for discovery of antibiotic 
resistance genes that are functionally 
compatible with the indicator strain in 
of this environmental antibiotic resistome 
by discovering hundreds of bacteria from 
diverse US soils that could consume a 
startling array of antibiotics as their sole 
carbon source, including both natural 
and entirely synthetic compounds.8 These 
antibiotic-metabolizing isolates are phylo-
genetically diverse, and many are closely 
related to known human pathogens, 
including members of the Burkholderiales, 
Pseudomonales and Enterobacteriales. We 
also found these bacteria to be extensively 
resistant to most antibiotics tested at over 
50 times the concentrations used to define 
clinical drug resistance—indeed, over a 
quarter of our isolates were resistant to all 
18 compounds tested at 1 mg/mL.
Much of the immense and diverse reser-
voir of antibiotic resistance genes present in 
the environment has not yet been observed 
in human pathogenic bacteria.5,9 However, 
the direct and continuous contact between 
farm animals and the soil increases the pos-
sibility of genetic exchange between their 
associated microbiomes, allowing for the 
transfer and selection of potentially novel 
soil resistance genes in farm animal associ-
ated microbiomes. It is clear that the large 
quantities of antibiotics currently used in 
agriculture selects for resistance genes in 
microbes associated with farm animals,10 
and these antibiotic resistant microbes can 
be directly transferred to human associated 
microbiomes.11 Thus, an environmental 
reservoir of microbial genes of particular 
relevance to human health is that har-
bored within the human-associated micro-
biome.12-15 Outnumbering human cells 
ten to one, and human genes a hundred 
to one, this microbial community sig-
nificantly impacts human health, includ-
ing beneficial roles in dietary processing 
and prevention of pathogen intrusion.16,17 
Given the widespread use of antibiotics 
in human medicine and their broad spec-
trum activities, the human microbiome 
has likely undergone substantial responsive 
changes to this therapy. This prompts the 
investigation of the extent to which the 
human associated microbiome in the anti-
biotic era has evolved to become a reservoir 
of antibiotic resistance genes.
During the progression of a bacterial 
infection in the human body, a multiply-
ing pathogen must interact with the com-
mensal microflora at the site of infection, 
to a conjugative plasmid previously iso-
lated from a multidrug-resistant strain of 
the bubonic plague bacterium Yersinia 
pestis.3 This mobile element conferred 
resistance to 6 different drugs including 
tetracycline and chloramphenicol, the two 
first-line drugs against the plague bacte-
rium. Consequently, there is an increasing 
interest in identifying and characterizing 
microbes from communities that may 
be accessible reservoirs of antibiotic 
resistance machinery.
Most antibiotics used in the clinic 
today are structural derivatives of com-
pounds isolated from natural sources. 
Since antibiotics in nature represent one 
of the oldest forms of biochemical warfare, 
environmental bacteria would be expected 
to possess intrinsic mechanisms to detect, 
resist, and neutralize these threats to their 
existence, and hence represent a reservoir 
of accessible resistance machinery. Indeed, 
a significant reservoir of antibiotic resis-
tance determinants have been highlighted 
in the soil microbiota, recently collectively 
termed the antibiotic resistome.4-6 While a 
majority of these antibiotic resistant organ-
isms in the soil are likely non-pathogenic, 
their biochemical mechanisms of resistance 
have been found to be identical to those of 
resistant clinical pathogens,7 which sug-
gests the soil resistome may constitute an 
important source of resistance mechanisms 
for clinical pathogens. A key subset of the 
soil antibiotic resistome is microbes which 
produce antibiotics, since they must, at the 
minimum, harbor self-immunity elements 
against the antimicrobial toxins which 
they produce. Since a significant majority 
of antibiotic chemicals are natural prod-
ucts or their semi-synthetic derivatives, 
it follows that producer microbes harbor 
microbial resistance mechanisms against 
a majority of antibiotics.7 This hypoth-
esis was elegantly supported by D’Costa 
et al. who, recognizing that soil-dwelling 
Actinomycetes produce over 50% of 
known antibiotics, profiled the antibiotic 
resistance of a library of 480 Streptomyces 
strains (an Actinomycete genus), and 
found them to be on average resistant to 
7–8 out of a set of 21 antibiotics tested, 
which encompassed every known class of 
antibiotic bacterial target, including com-
pletely synthetic antibiotics.5 We recently 
helped significantly expand the concept 
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54.9% at the amino acid level) to previ-
ously characterized genes harbored by 
pathogens (Fig. 1A). Amongst the genes 
encoding resistance to beta-lactam anti-
biotics, we identified 10 new sequence 
families (HGA to HGI and HOA), each 
with sequence identity less than 61% at 
the amino acid level to previously char-
acterized resistance gene products. The 
DNA inserts containing antibiotic resis-
tance genes appeared to predominantly 
originate from the phyla Bacteroidetes and 
Firmicutes, based on phylogenetic analysis 
using PhyloPythia.23 Previous studies have 
demonstrated that the gut microbiome is 
indeed dominated (>90%) by these two 
phyla, from which the minority (∼20%) 
of phylotypes are cultured obligate anaer-
obes, while the majority (∼80%) remain 
uncultured.16 While Firmicutes and 
suppress specific dominant antibiotic sus-
ceptibility loci allowing complementation 
by a transferred resistance gene that is oth-
erwise recessive. Despite current limita-
tions, metagenomic functional selections 
are useful for the identification of numer-
ous known as well as novel resistance 
genes, since their success is independent of 
prior knowledge of the sequence of previ-
ously identified genes.
We recently used metagenomic func-
tional selections to identify several hun-
dred resistance genes harbored by the 
microbiome of healthy individuals.22 First, 
we used microbiome-wide culture inde-
pendent functional selections to identify 
the prevalent antibiotic resistance genes 
of the human microbiome. Interestingly 
these genes had low sequence identity 
(on average 60.7% at the nucleotide and 
absence of any prior knowledge of their 
DNA sequence. However, metagenomic 
functional selections for characterization 
of resistance reservoirs have certain limi-
tations as well. These primarily involve 
the requirement for (1) host susceptibility 
to the antibiotics assayed, (2) appropriate 
translation and functional compatibility 
of heterologous gene products in the host, 
and (3) the resistance gene to encode a 
dominant phenotype that overcomes the 
host mechanism of susceptibility. Methods 
to overcome these limitations include (1) 
use of multiple host strains which span 
the spectrum of antibiotic susceptibility 
mechanisms assayed, (2) engineering of 
new host strains with an expanded reper-
toire of translational machinery including 
rare codon transfer RNAs, and (3) the use 
of conditional host strain mutants which 
Figure 1. distribution of nucleotide identities for (A) 93 resistance genes identified from dnA extracted directly from saliva and fecal samples and 
(B) 114 resistance genes identified from cultured aerobic gut isolates to the most similar resistance gene harbored by a pathogenic isolate in ncBi 
GenBank.
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genes harbored by human gut microbes 
capable of growing aerobically on rich 
media were more than 90% identical at 
the nucleotide level to resistance genes in 
pathogenic isolates (Fig. 1B).
This work exposed the significant 
under-sampling of antibiotic resistance 
genes in the human microbiome, which 
has resulted from the reliance on culture 
dependent methods, and demonstrates the 
utility and importance of using metage-
nomic functional selections for studying 
antibiotic resistance reservoirs. While we 
found a large number of microbial DNA 
fragments encoding resistance genes that 
have never before been described, our 
analysis suggests that we have just begun 
to scratch the surface of the immense 
diversity of antibiotic resistance machin-
ery in the human microbiome and we 
estimate that complete sequencing of 
these libraries would yield hundreds more 
resistance genes.22 When we compare the 
resistance genes derived from the microbi-
omes of the two different individuals, we 
find that over 65% of the resistance genes 
derived from cultured aerobes are highly 
similar (>90% nucleotide sequence iden-
tity) between the two individuals, whereas 
less than 10% of the metagenomically 
derived resistance genes are highly simi-
lar between the two individuals (Fig. 2). 
Furthermore, all of the genes (metage-
nomic and cultured gut aerobes) shared 
between individuals have close homologs 
(>90% nucleotide sequence identity) in 
GenBank. Interestingly, while 84% of 
the genes unique to an individual from 
cultured aerobic isolates also have close 
homologs in GenBank, only 11% of the 
metagenomically derived genes unique 
to an individual have close homologs in 
GenBank (Fig. 2). These results suggest 
that the under-sampled antibiotic resis-
tance reservoir accessed by our metage-
nomic functional selection approach is 
extremely diverse compared to the well 
studied subset of cultured gut aerobes 
and merits application to a larger number 
of individuals. Also, in spite of the sparse 
sampling of this work, the results seem 
to indicate that the antibiotic resistance 
reservoir sampled using culture indepen-
dent methods is shared to a lesser extent 
amongst individuals compared to that of 
the cultured aerobic isolates.
treatment. As a consequence of their 
normal low abundance in healthy indi-
viduals, they are not well represented in 
libraries made using an unbiased func-
tional metagenomic approach. Given 
their potential importance as a reservoir 
of antibiotic resistance genes readily acces-
sible to closely related human pathogens, 
we assayed for the capacity of culturable 
aerobic bacteria to grow in the presence of 
antibiotics and elucidated their resistance 
genes using functional selections. Notably, 
the antibiotic resistance genes harbored by 
this subset of the human microbiome were 
highly similar to previously character-
ized resistance genes and included several 
genes such as TetA, a tetracycline efflux 
pump, and CTX-M-15, an epidemic beta-
lactamase, frequently found in pathogenic 
isolates. In fact, over 95% of the resistance 
Bacteroidetes include important human 
pathogens such as Staphylococcus aureus, 
Streptococcus pneumoniae and Bacteroides 
fragilis, we found that the majority of our 
genes have low sequence identity to resis-
tance genes previously identified in these 
closely related pathogens. A number of 
human pathogens are also readily cultur-
able facultative anaerobic Proteobacteria, 
including epidemic strains of Klebsiella 
pneumoniae, Serratia marcescens, Shigella 
sonnei, Salmonella typhimurium, Vibrio 
cholerae and Haemophilus influenzae. 
While Proteobacteria constitute less than 
1% of the human gut microbiome,16 they 
are seen to dramatically increase in abun-
dance during antibiotic treatment at the 
expense of the normally abundant gut 
microbes,24,25 indicating that they have 
increased relative fitness during antibiotic 
Figure 2. Overlap of resistance genes identified from the human microbiomes of two healthy 
unrelated individuals. resistance genes from two individuals are compared to each other and 
defined as being shared if they have greater than 90% sequence identity at the nucleotide level. 
resistance genes identified using metagenomic functional selections (top) are shared between 
two individuals to a much lesser extent than resistance genes identified from cultured gut isolates 
(bottom). notably, all resistance genes that are shared between the two individuals also have 
high sequence identity (>90% at the nucleotide level) to previously characterized genes in ncBi 
GenBank.
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human microbiome are inaccessible or infre-
quently exchanged with human pathogens. 
However, all the resistance genes identified 
in this study are expressed and functional in 
E. coli, a readily culturable strain with close 
pathogenic relatives, which suggests that if 
a barrier to gene transfer exists between the 
constituents of the human microbiome and 
pathogens, it must stem from processes other 
than functional compatibility.
In light of the ever-increasing problems of 
antibiotic resistance in pathogens, a deeper 
and more quantitative understanding of the 
human microbiome as a reservoir for patho-
genesis is critical. Our initial work using 
metagenomic functional selections high-
lighted that an unappreciated diversity of 
antibiotic resistance genes is harbored by the 
dominant species of the human microbiome 
which had been missed likely due to reli-
ance on culture and PCR based techniques 
for interrogating this microbiome. However, 
this work only scratched the surface of this 
diverse reservoir and furhter in depth char-
acterization and quantitation across popula-
tions is needed to better understand how this 
reservoir is connected to other resistance res-
ervoirs and the extent to which this reservoir 
is accessible to pathogens.
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Given that 45% of the resistance genes 
from cultured human gut microbiome iso-
lates uncovered in this study are identical at 
the nucleotide level to resistance genes from 
human pathogenic isolates underscores their 
extremely close evolutionary relationship. 
While this identity provides no informa-
tion regarding the direction or mechanism 
of transfer, these results lead to a few for-
mal hypotheses regarding the evolution 
of an antibiotic resistant human pathogen 
through interactions with the human micro-
biome. First, the human microbiome may 
constitute a mobilizable reservoir of antibi-
otic resistance genes which are accessed by a 
pathogenic bacterium to acquire antibiotic 
resistance. Culturable isolates can transfer 
antibiotic resistance determinants to previ-
ously susceptible strains in vivo in the avian 
gut26 as well as in the gut of gnotobiotic 
mice27 and rats,28 but direct experimental 
proof of in vivo transfer of antibiotic resis-
tance genes within the human microbiome 
remains to be shown. Second, an antibiotic 
resistant member of the human microbi-
ome may become pathogenic through the 
acquisition of virulence genes derived from 
a pathogen.29 Finally, despite our selection 
of samples from healthy humans, the aero-
bic cultured microbiome isolates containing 
antibiotic resistance genes that are identical 
to those harbored by clinical pathogenic 
isolates may indeed themselves be dormant 
pathogens inhabiting the human microbi-
ome. In all these possibilities a multidrug 
resistant human microbiome may act as a 
reservoir for pathogenesis—either as a donor 
of antibiotic resistance genes, a recipient of 
virulence factors, or as a permissive environ-
ment for dormant pathogens. For this reason 
it will be critical to test these hypotheses in 
vivo, as well as determine the factors that are 
responsible for the maintenance and transfer 
of antibiotic resistance in the healthy human 
microbiome.
In contrast to cultured isolates, the resis-
tance genes uncovered using a culture inde-
pendent approach are largely novel and 
distantly related to resistance genes from even 
closely related pathogenic isolates, which 
may reflect an unappreciated barrier to lateral 
gene transfer in vivo between the dominant 
commensals in healthy humans and disease 
causing isolates. From the standpoint of a 
reservoir for pathogens, one interpretation of 
this finding is that the resistance genes of the 
